Kosher Shabbat-Compliant Search Results for Phases Drug


L'chaim! לחיים and welcome to JewJewJew.com - the world's first Shabbot compliant search engine.

JewJewJew.com complies with holy laws by ensuring:


JewJewJew.com - the worlds first search engine for Jews!
Website content last updated on Tuesday 2019-11-26
1
Alcohol and Drug Rehab Programs – Addiction Treatment Centers Straightforward education on drug addiction, alcohol abuse, and behavioral disorders. Learn about the tolerance, dependence, abuse, addiction and recovery phases.
3
Alcohol and Drug Rehab Programs – Addiction Treatment Centers Straightforward education on drug addiction, alcohol abuse, and behavioral disorders. Learn about the tolerance, dependence, abuse, addiction and recovery phases.
6
A global contract research organization (CRO) that offers a full spectrum of resources to meet the drug discovery and drug development needs of the pharmaceutical and biotechnology industries. With facilities in more than 23 countries, MDS Pharma Services applies advanced scientific and technological expertise to each stage of the drug discovery and development process: discovery, preclinical, early clinical research (phases I-IIa), bioanalytical, global clinical research (phases IIb-IV), and central lab.
7
A global contract research organization (CRO) that offers a full spectrum of resources to meet the drug discovery and drug development needs of the pharmaceutical and biotechnology industries. With facilities in more than 23 countries, MDS Pharma Services applies advanced scientific and technological expertise to each stage of the drug discovery and development process: discovery, preclinical, early clinical research (phases I-IIa), bioanalytical, global clinical research (phases IIb-IV), and central lab.
8
Treatment Courts Online The Veterans Treatment Court model requires regular court appearances (a bi-weekly minimum in the early phases of the program), as well as mandatory attendance at treatment sessions and frequent and random testing for substance use (drug and/or alcohol).  Veterans respond favorably to this structured environment given their past experiences in the Armed Forces.  However, a few will struggle and it is exactly those veterans who need a Veterans Treatment Court program the most.  Without this structure, these veterans will reoffend and remain in the criminal justice system.  The Veterans Treatment Court is able to ensure they meet their obligations to themselves, the court, and their community.
9
Treatment Courts Online The Veterans Treatment Court model requires regular court appearances (a bi-weekly minimum in the early phases of the program), as well as mandatory attendance at treatment sessions and frequent and random testing for substance use (drug and/or alcohol).  Veterans respond favorably to this structured environment given their past experiences in the Armed Forces.  However, a few will struggle and it is exactly those veterans who need a Veterans Treatment Court program the most.  Without this structure, these veterans will reoffend and remain in the criminal justice system.  The Veterans Treatment Court is able to ensure they meet their obligations to themselves, the court, and their community.
10
Cyclacel Pharmaceuticals, Inc. | Biopharmaceutical company developing cell cycle control cancer therapies Cyclacel is a biopharmaceutical company, based in Berkeley Heights, New Jersey and Dundee, Scotland, that develops orally available small molecule drugs which target various cell cycle phases to control cancer and other serious diseases.
11
Cyclacel Pharmaceuticals, Inc. | Biopharmaceutical company developing cell cycle control cancer therapies Cyclacel is a biopharmaceutical company, based in Berkeley Heights, New Jersey and Dundee, Scotland, that develops orally available small molecule drugs which target various cell cycle phases to control cancer and other serious diseases.
12
Adult & Teen Challenge | Shenandoah Valley Teen Challenge Virginia Shenandoah Valley Adult & Teen Challenge is a Residential Drug & Alcohol Program located in Virginia, part of the Adult & Teen Challenge USA Network
13
Adult & Teen Challenge | Shenandoah Valley Teen Challenge Virginia Shenandoah Valley Adult & Teen Challenge is a Residential Drug & Alcohol Program located in Virginia, part of the Adult & Teen Challenge USA Network
14
American Journal of Acupuncture: Serving Our Readers With The Most Comprehensive Collection of Contemporary Research and Experience Since 1973, the American Journal of Acupuncture has provided peer-reviewed articles spanning the diverse range of traditional and modern acupuncture and energy medicine. As the world''s most comprehensive collection of contemporary-practitioner''s research and experience, AJA offers treatment options and evidence, unique applications of acupuncture in the Western setting, clinical comparisons and research, treatment innovations including advances in pain management, herbal medicine, nutrition, and immune enhancement. Regular features include the Acu-Forum (with review and insight on the fundamentals by a senior practitioner), as well as book and equipment reviews, etc. Special series have included in-depth exploration of specific clinical topics, perspectives on healing traditions, as well as the future of Oriental medicine, bioelectromagnetics and the coming paradigm shift. AJA''s authors have included the world''s most renowned teachers, practitioners, researchers, scholars--all representing diverse traditions and perspectives in the field. In this forum, no school or perspective or training orientation is favored above any other--they all have their place in the evolving field. Sample topics: Parkinsonism, sportsmedicine, cellulite, sexual abuse, hiccups during surgery, edema, stroke, bone spurs, loss of taste, alcoholic recidivism, autoimmune disease, dangers of dairy products, colorpuncture, etc. Back issues for continued and unique professional enrichment are available.
16
Health Point community health point relate to health fitness, recipes, women health, general health weight management, diet and vitamin
17
Life Science Investing News | Investing News Network Within the universe of investment options available to those trying to grow their hard-earned cash, there is perhaps no more compelling investment thesis than the science of life. Life sciences is a term that is broadly defined as any branch of science — for instance, biology, medicine or ecology — that studies the organization of living organisms, their relationships to each other and the environment. The sector is generally divided into pharmaceutical companies, which focus on chemistry and small molecules, and biotechnology companies, which use living organisms or their derivatives to make products for specific healthcare uses. There are also companies that focus on diagnostic testing and firms that make medical devices that manage pain and check for irregularities in bodily functions. Over the years, as medical science and other technologies, like computing power, have advanced, the industry has morphed into a sector containing hundreds of companies, some of which have market capitalizations well over $50 billion. With healthcare eating up an ever-greater proportion of government budgets — last year, health expenditures represented close to a quarter (23 percent) of government spending in the United States — and the western world’s reliance on pharmaceutical drugs unlikely to abate, investing in health-related companies is a solid investment strategy. While the life sciences sector is not immune to the vagaries of stock markets and macroenomic trends such as inflation and economic growth, recent numbers show that it has done quite well in the face of some challenging economic headwinds. The Wall Street Journal reported that healthcare mutual funds “gained 19.7% on average in the 12 months through Nov. 15, [2012], and are up 12.6% each year over the past three years,” according to investment-research firm Morningstar. By comparison, the S&P 500 (INDEXSP:.INX) stock index gained 10.1 percent during the same period. The sector is also considered a safe haven due to baby boomers — a large and growing market segment whose consumption of pharmaceuticals and need for an endless array of healthcare services is only going to get more pressing. Harry Dent, bestselling author and financial forecaster, said this month that he sees life sciences as a good place for investors to be, particularly due to continuing economic uncertainty. “If I am right, and stocks crash again in late 2014 or early 2015, I want to buy in the healthcare sector in the U.S. and Europe, especially the most leveraged areas: biotech, medical devices and pharmaceuticals. The baby boomers will continue spending on healthcare and healthcare products, even as budgets get crimped by entitlement reductions,” he noted. Small-pharma, cancer treatment are investment targets John McCamant is the editor of the Medical Technology Stock Letter, an established source for stock recommendations and news about medical technology companies. McCamant believes that from an investor point of view, pharmaceutical companies carry the best chance of high returns considering their potential for developing cures for intractable diseases like cancer, Alzheimer’s disease and multiple sclerosis. Companies that succeed in finding cures can develop drugs whose patient costs run up to $100,000 a year; while that is a heavy burden to pass onto a patient, it translates into huge profits for the corporations that manufacture such drugs. Investors who get into these stocks early enough can see returns in excess of 10 times their original investment. However, there are risks, an important one being side effects from drugs. For example, those associated with chemotherapy can make the treatment unworthy of the payoff. McCamant equates it to the stock market in terms of risk versus reward. “It’s risk versus benefit or greed versus reward,” he said in an interview with Life Science Investing News. “How much effect am I having on the patient versus the side effects?” McCamant also noted that unlike the resource or tech sectors, where there is normally a stark division between academia and business, in pharmaceuticals the line is blurred, with about half of new drugs coming out of universities. That means that investors interested in life sciences should keep their ears to the ground on discoveries made at medical schools or associated institutes. “They often start off with some interesting science and then the companies form and start creating different molecules to go after the technology they own,” he said, adding that drug company CEOs often start out as academics or scientists. “The technology has shoes — often the guys will start off at universities and move into commercial.” Cancer treatment is an area that McCamant sees as an important area for life sciences investors to consider. He pointed to the high-profile case of NHL hockey star Mario Lemieux, who in 1993 was diagnosed with Hodgkin’s lymphona and was forced to miss games while undergoing aggressive radiation treatments. The Pittsburgh Penguins forward was prescribed the cancer drug Rituxan and within two months was back on the ice, his cancer in remission. Rituxan, manufactured by Genentech, is now one of the world’s largest selling drugs, thanks in part to the publicity generated from the Mario Lemieux story. “That’s where we get excited is that when you get to the actual cause of disease and maybe you can create a cure and and get close, you’re certainly going to get better treatments and fewer side effects,” McCamant said. Number one rule for investors: look at management But given that literally hundreds of companies are conducting research and studies into potential cures, how does an investor separate the wheat from the chaff? McCamant recommended that investors do their homework, and most importantly, look at the management behind life sciences companies. Very often, the people running these companies need to come with a diverse set of skills in order to understand the complex science behind the treatments and to communicate that understanding to an investor audience. “These are some of the hardest companies in the world to run in terms of the level of complexity,” said McCamant. “You’ve got to be able to interact with your own scientists, the FDA are very detailed and they also need to know and understand the science, and if you’re public you need to deal with Wall Street. You also need to potentially do partnerships with large and small companies.” Those that do well are the ones that best manage expectations, he noted. Another common mistake: “don’t rush into an investment and make sure you know what you’re getting into on multiple levels.” McCamant pointed out that investors need to be aware of the phases that most life sciences companies go through as they advance from initial drug testing to human clinical trials, to eventual commercialization. Timing it right can result in every investor’s dream of a 10 bagger. Mistime it and your gains could quickly turn to losses, especially if the company has poor testing data or runs afoul of the FDA, whose job is to protect the public. And like other sectors, it’s important to watch out for red flags such as overdilution, or what McCamant describes as “monsters,” such as Obamacare, which resulted in the whole sector trading off. Those who persevere, however, may not only be rewarded with handsome returns, but can also sleep well at night, secure in the knowledge that their investment is actually helping to change people’s lives in a positive way. “We’re making a difference at the end of the day, it’s not trivial in any form,” McCamant said.
23
Dogma and Geopolitics | When we blindly adopt a religion, a political system, a literary dogma, we become automatons. We cease to grow. ~Anais Nin When we blindly adopt a religion, a political system, a literary dogma, we become automatons. We cease to grow. ~Anais Nin
24
Chromsystems Instruments & Chemicals Homepage Chromsystems offers best-in-class technologies for clinical analysis by HPLC and mass spectrometry. Our solutions are used worldwide in hundreds of clinical laboratories and help to provide reliable and accurate results that doctors and patients can truly rely on. We also ensure that our products are economic and simple to use.
25
GOSTAR | Global Online Structure Activity Relationship Database | Online Scientific Database Online database that integrates information on compounds in discovery, development and drug phases, including SAR, ADME, toxicity, preclinical, clinical and structural data over 6.6 million inhibitors and over 22 million quantitative SAR points.
27
Chromsystems Instruments & Chemicals Homepage Chromsystems offers best-in-class technologies for clinical analysis by HPLC and mass spectrometry. Our solutions are used worldwide in hundreds of clinical laboratories and help to provide reliable and accurate results that doctors and patients can truly rely on. We also ensure that our products are economic and simple to use.
28
Pyramid Laboratories, Inc. | Aseptic Filling and Pharmaceutical Lyophilization Services Contract Manufacturer and Analytical Service provider for all phases of drug development. Pharmaceutical Lyophilization Services, Aseptic Filling, Formulation & Process Development. Based in Costa Mesa, California.
29
IHMA International Health Management Associates IHMA specializes in infectious diseases & offer the most comprehensive offering of products and services for developing and marketing antimicrobial agents
30
RDAP BOP Federal Sentence Reductions | Wall Street Prison Consultants Going to Federal Prison? Need an RDAP sentence reduction. We help federal defendants qualify for the Federal Bureau of Prisons Residential Drug Abuse and Second Chance Act early release programs. Former BOP inmates Larry Levine and Holli Coulman guide you through all phases of federal custody.
31
Anania Mothers and Children Specialized Medical Center Our goal is to provide the highest quality medical care available for Mothers, Infants and Children. We have established a successful and comfortable patient-physician relationship, where you can expect to be treated professionally and courteously at all times
32
Pyramid Laboratories, Inc. | Aseptic Filling and Pharmaceutical Lyophilization Services Contract Manufacturer and Analytical Service provider for all phases of drug development. Pharmaceutical Lyophilization Services, Aseptic Filling, Formulation & Process Development. Based in Costa Mesa, California.
35
Dogma and Geopolitics | When we blindly adopt a religion, a political system, a literary dogma, we become automatons. We cease to grow. ~Anais Nin When we blindly adopt a religion, a political system, a literary dogma, we become automatons. We cease to grow. ~Anais Nin